| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| OEM(元) | 73,533,733.49 | 210,466,252.84 | 159,843,378.11 |
| 电生理(元) | 223,317,589.50 | 367,530,175.59 | 292,836,994.54 |
| 冠脉通路类(元) | 503,229,514.24 | 791,095,551.12 | 569,222,603.01 |
| 外周介入类(元) | 175,211,576.07 | 256,242,748.21 | 182,560,719.72 |
| 非血管介入类(元) | 16,350,926.25 | 16,388,806.02 | - |
| 营业成本(元) | |||
| OEM(元) | 28,561,255.07 | 79,104,079.41 | 55,393,336.71 |
| 电生理(元) | 57,967,836.68 | 93,914,223.02 | 64,470,154.99 |
| 冠脉通路类(元) | 129,833,050.63 | 222,503,896.44 | 174,313,763.33 |
| 外周介入类(元) | 42,157,367.56 | 64,696,324.05 | 51,746,029.29 |
| 非血管介入类(元) | 7,110,507.43 | 8,197,305.25 | - |
| 毛利(元) | |||
| OEM(元) | 44,972,478.42 | 131,362,173.43 | 104,450,041.40 |
| 电生理(元) | 165,349,752.82 | 273,615,952.57 | 228,366,839.55 |
| 冠脉通路类(元) | 373,396,463.61 | 568,591,654.68 | 394,908,839.68 |
| 外周介入类(元) | 133,054,208.51 | 191,546,424.16 | 130,814,690.43 |
| 非血管介入类(元) | 9,240,418.82 | 8,191,500.77 | - |
| 毛利率(%) | |||
| OEM(%) | 61.16 | 62.41 | 65.35 |
| 电生理(%) | 74.04 | 74.45 | 77.98 |
| 冠脉通路类(%) | 74.20 | 71.87 | 69.38 |
| 外周介入类(%) | 75.94 | 74.75 | 71.66 |
| 非血管介入类(%) | 56.51 | 49.98 | - |
| 收入构成(%) | |||
| OEM(%) | 7.42 | 12.82 | 13.27 |
| 电生理(%) | 22.52 | 22.39 | 24.31 |
| 冠脉通路类(%) | 50.75 | 48.19 | 47.26 |
| 外周介入类(%) | 17.67 | 15.61 | 15.16 |
| 非血管介入类(%) | 1.65 | 1.00 | - |
| 毛利构成(%) | |||
| OEM(%) | 6.19 | 11.20 | 12.17 |
| 电生理(%) | 22.78 | 23.32 | 26.60 |
| 冠脉通路类(%) | 51.43 | 48.46 | 46.00 |
| 外周介入类(%) | 18.33 | 16.33 | 15.24 |
| 非血管介入类(%) | 1.27 | 0.70 | - |